NIKKEI 225
27,782.93 -100.85 (-0.36%) HANG SENG
20,309.13 +116.73 (+0.58%) CRUDE OIL
74.35 +1.38 (+1.89%) GOLD FUTURES
1,981.60 +14.70 (+0.75%) DOW
32,859.03 +141.43 (+0.43%) Bitcoin GBP
22,542.62 -401.31 (-1.75%)
GH Dec 2023 50.000 put
| Previous close | 20.80 |
| Open | 21.10 |
| Bid | 24.10 |
| Ask | 27.00 |
| Strike | 50.00 |
| Expiry date | 2023-12-15 |
| Day's range | 20.80 - 21.10 |
| Contract range | N/A |
| Volume | |
| Open interest | 270 |
- Zacks
Here's Why Guardant Health (GH) Looks Ripe for Bottom Fishing
Guardant Health (GH) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
- Business Wire
Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence
PALO ALTO, Calif., March 21, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has announced support for an investigator initiated study led and conducted by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) to evaluate patient compliance with a blood-based test for colorectal cancer (CRC) screening. In this study, The Ohio State University Guardant Shield Colorectal Canc
- Simply Wall St.
In the wake of Guardant Health, Inc.'s (NASDAQ:GH) latest US$536m market cap drop, institutional owners may be forced to take severe actions
Key Insights Institutions' substantial holdings in Guardant Health implies that they have significant influence over...
